Dawnrays Pharmaceutical Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
694.00
502.00
581.00
585.00
393.00
369.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-183.00
24.00
-6.00
6.00
-28.00
-27.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
279.00
399.00
519.00
483.00
347.00
334.00
Cash Flow from Investing Activities
178.00
-454.00
-217.00
-343.00
31.00
-705.00
Cash Flow from Financing Activities
-201.00
2.00
-108.00
-165.00
-380.00
80.00
Net Cash Inflow / Outflow
269.00
-49.00
202.00
-24.00
-3.00
-302.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
14.00
2.00
8.00
0.00
-2.00
-11.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dawnrays Pharmaceutical Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
694.602583584038
917.124348121456
-223.00
-24.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-183.886532137174
-61.4050173202362
-122.00
-199.46%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
279.524833061032
1202.2470288802
-923.00
-76.75%
Cash Flow from Investing Activities
178.247483932286
-986.605748844508
1,164.00
118.07%
Cash Flow from Financing Activities
-201.969217382536
-553.317374664478
352.00
63.50%
Net Cash Inflow / Outflow
269.808018984468
-321.214324028036
590.00
184.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
14.0049193736859
16.4617706007442
-2.00
-14.92%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -30.02% vs -23.07% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
279.52
399.45
-30.02%






